Groupe Bruxelles Lambert → Concentrix Corp CNXC

Stake: 14.24% Shares: 8,773,667 CUSIP: 20602D101 Class: Common Stock, par value $0.0001 per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 33/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: -29.4%

Passive Schedule 13G filer baseline
High conviction ownership stake (14.2%)
Held by 1 tracked 13F institutional manager
13 NPORT-P mutual funds holding CUSIP
Elevated short days-to-cover (6.1 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 6.07

8,706,258 shares short · -4.9% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $1.42M

Point72 Asset Mgmt

Post-Filing Returns · since 2026-01-28 on CNXC

+1 day

+6.3%

+5 days

+10.3%

+30 days

-8.8%

+60 days

-25.9%

+90 days

-29.4%

+180 days

-30.8%

Anchor price 35.50 on closest trading day on/after 2026-01-28. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Other 13D/G Filings on Concentrix Corp

Filed	Form	Filer	Stake	Shares
2025-11-07	SCHEDULE	Impactive Capital LP	4.90%	3,066,213	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →